De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Blonder Tongue Laboratories Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Bob Palle

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	1.6yrs
Eigendom CEO	16.8%
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	14.1yrs

Recente managementupdates

Recent updates

Have Blonder Tongue Laboratories, Inc. (NYSEMKT:BDR) Insiders Been Selling Their Stock?

Dec 23

Analyse CEO-vergoeding

Hoe is Bob Palle's beloning veranderd ten opzichte van Blonder Tongue Laboratories's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Dec 31 2022	US$27k	n/a	-US$3m
Sep 30 2022	n/a	n/a	-US$4m
Jun 30 2022	n/a	n/a	-US$3m
Mar 31 2022	n/a	n/a	-US$656k
Dec 31 2021	US$38k	n/a	US$84k
Sep 30 2021	n/a	n/a	-US$1m
Jun 30 2021	n/a	n/a	-US$3m
Mar 31 2021	n/a	n/a	-US$6m
Dec 31 2020	n/a	n/a	-US$7m
Sep 30 2020	n/a	n/a	-US$9m
Jun 30 2020	n/a	n/a	-US$8m
Mar 31 2020	n/a	n/a	-US$8m
Dec 31 2019	US$534k	US$491k	-US$742k
Sep 30 2019	n/a	n/a	US$2m
Jun 30 2019	n/a	n/a	US$3m
Mar 31 2019	n/a	n/a	US$4m
Dec 31 2018	US$170k	US$60k	-US$1m
Sep 30 2018	n/a	n/a	-US$341k
Jun 30 2018	n/a	n/a	-US$295k
Mar 31 2018	n/a	n/a	-US$191k
Dec 31 2017	US$161k	US$42k	-US$384k

Compensatie versus markt: Er zijn onvoldoende gegevens om vast te stellen of de totale vergoeding van Bob redelijk is in vergelijking met bedrijven van vergelijkbare omvang in de US markt.

Compensatie versus inkomsten: Er zijn onvoldoende gegevens om de beloning van Bob te vergelijken met de prestaties van het bedrijf.

CEO

Bob Palle (78 yo)

1.6yrs

Tenure

US$26,542

Compensatie

Mr. Robert J. Palle, Jr., also known as Bob, has been the Chief Executive Officer and President at Blonder Tongue Laboratories, Inc. since March 17, 2023. Mr. Palle serves as Director of Blonder Tongue Lab...

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Robert Palle	CEO, President & Director	31.1yrs	US$26.54k	16.84% $ 198.0k
Gary Scharmett	Independent Director	26.8yrs	US$26.54k	1.99% $ 23.4k
James Williams	Independent Director	31.1yrs	US$26.54k	1.61% $ 19.0k
Stephen Necessary	Independent Director	6.8yrs	US$26.54k	1.34% $ 15.8k
Steven Shea	Independent Chairman	15.1yrs	US$26.54k	4.51% $ 53.0k
Charles Dietz	Independent Director	13.1yrs	US$26.54k	2.02% $ 23.8k
John Burke	Independent Director	4.8yrs	US$26.54k	0.027% $ 314.8
Michael Hawkey	Independent Director	4.3yrs	US$26.54k	0.076% $ 893.8

14.1yrs

Gemiddelde duur

66.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van BDRL zijn ervaren en ervaren (gemiddelde ambtstermijn van 14.1 jaar).

Blonder Tongue Laboratories Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Blonder Tongue Laboratories, Inc. Announces the Retirement of Stephen K. Necessary from the Board

Blonder Tongue Laboratories, Inc. Announces President Changes

Blonder Tongue Laboratories, Inc. Announces Furloughing Ronald V. Alterio, the Senior Vice President-Engineering and Chief Technology Officer

Blonder Tongue Laboratories, Inc. Announces Resignation of Anthony Bruno as BOD, Effective from May 25, 2022

Blonder Tongue Laboratories, Inc., Annual General Meeting, May 25, 2022

Blonder Tongue Laboratories, Inc. Announces Retirement of James H. Williams as Member of the Board of Director

Recent updates

Blonder Tongue Announces IP Failover Feature Added to NXG Video Delivery System

Blonder Tongue Laboratories, Inc. Announces the Retirement of Stephen K. Necessary from the Board

Blonder Tongue Laboratories, Inc. Announces President Changes

Blonder Tongue Laboratories, Inc. to Report Q3, 2022 Results on Nov 04, 2022

Blonder Tongue Laboratories Announces Product Standardization with Tier One Broadband Cable Operator

Blonder Tongue Laboratories, Inc. to Report Q2, 2022 Results on Aug 15, 2022

Blonder Tongue Laboratories, Inc.(OTCPK:BDRL) dropped from S&P TMI Index

NYSE American to Suspend Trading Immediately in Blonder Tongue Laboratories

Blonder Tongue Laboratories, Inc. Announces Furloughing Ronald V. Alterio, the Senior Vice President-Engineering and Chief Technology Officer

Blonder Tongue Laboratories, Inc. Announces Resignation of Anthony Bruno as BOD, Effective from May 25, 2022

Blonder Tongue Laboratories, Inc., Annual General Meeting, May 25, 2022

Blonder Tongue Laboratories, Inc. Announces Retirement of James H. Williams as Member of the Board of Director

NYSE American to Commence Delisting Proceedings Against Blonder Tongue Laboratories

Independent Director Rick Briggs has left the company

Independent Director recently sold US$102k worth of stock

Third quarter 2021 earnings released: US$0.016 loss per share (vs US$0.18 loss in 3Q 2020)

Second quarter 2021 earnings released: EPS US$0.14 (vs US$0.12 loss in 2Q 2020)

Director recently sold US$74k worth of stock

First quarter 2021 earnings released: US$0.036 loss per share (vs US$0.21 loss in 1Q 2020)

Full year 2020 earnings released: US$0.76 loss per share (vs US$0.077 loss in FY 2019)

Independent Director recently sold US$77k worth of stock

Blonder Tongue Laboratories, Inc. announced that it has received $0.6 million in funding

New 90-day high: US$1.85

MD of Strategic Accounts & Director recently sold US$52k worth of stock

Have Blonder Tongue Laboratories, Inc. (NYSEMKT:BDR) Insiders Been Selling Their Stock?

Blonder Tongue Laboratories Receives Non-Compliance Letter from NYSE American

New 90-day high: US$1.75

Third quarter 2020 earnings released: US$0.18 loss per share

New 90-day high: US$1.50

NYSE Accepts Compliance Plan of Blonder Tongue Laboratories, Inc

New 90-day high - US$1.35

Earnings released

Blonder Tongue Laboratories, Inc. to Report Q2, 2020 Results on Aug 07, 2020